Evidence map›Paper›PMID 26706541›Full record

ArticleMaterials science & engineering. C, Materials for biological applications2016

Chitosan-PLGA polymer blends as coatings for hydroxyapatite nanoparticles and their effect on antimicrobial properties, osteoconductivity and regeneration of osseous tissues.

Nenad Ignjatović, Victoria Wu, Zorica Ajduković, Tatjana Mihajilov-Krstev, Vuk Uskoković, Dragan Uskoković

Open access · greenAbstract read
In one paragraph

Article in Materials science & engineering. C, Materials for biological applications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Effects of hydroxyapatite@poly-lactide-Toxicology research · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nenad IgnjatovićInstitute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/IV, P.O. Box 377, 11000 Belgrade, Serbia.
Victoria WuAdvanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, College of Engineering and College of Medicine, University of Illinois at Chicago, Chicago, USA.
Zorica AjdukovićUniversity of Niš, Faculty of Medicine, Clinic of Stomatology, Department of Prosthodontics, Bulevar Zorana Djindjica 81, 18000 Niš, Serbia.
Tatjana Mihajilov-KrstevUniversity of Niš, Faculty of Science and Mathematics, Department of Biology and Ecology, Višegradska 33, P. O. Box 224, 18000 Niš, Serbia.
Vuk UskokovićAdvanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, College of Engineering and College of Medicine, University of Illinois at Chicago, Chicago, USA.
Dragan UskokovićInstitute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/IV, P.O. Box 377, 11000 Belgrade, Serbia. Electronic address: dragan.uskokovic@itn.sanu.ac.rs.
Serbian Academy of Sciences and Arts · RSUniversity of Illinois Chicago · USUniversity of Nis · RS

Funding

Osteogenic Calcium Phosphate Nanoparticles with Designable Drug Release KineticsR00DE021416 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI USKOKOVIC, VUK · 2014 to 2016
$727k
NIDCR NIH HHS R00 DE021416NIDCR NIH HHS R00-DE021416
6 · The paper itself

Abstract

Composite biomaterials comprising nanostructured hydroxyapatite (HAp) have an enormous potential for natural bone tissue reparation, filling and augmentation. Chitosan (Ch) as a naturally derived polymer has many physicochemical and biological properties that make it an attractive material for use in bone tissue engineering. On the other hand, poly-D,L-lactide-co-glycolide (PLGA) is a synthetic polymer with a long history of use in sustained drug delivery and tissue engineering. However, while chitosan can disrupt the cell membrane integrity and may induce blood thrombosis, PLGA releases acidic byproducts that may cause tissue inflammation and interfere with the healing process. One of the strategies to improve the biocompatibility of Ch and PLGA is to combine them with compounds that exhibit complementary properties. In this study we present the synthesis and characterization, as well as in vitro and in vivo analyses of a nanoparticulate form of HAp coated with two different polymeric systems: (a) Ch and (b) a Ch-PLGA polymer blend. Solvent/non-solvent precipitation and freeze-drying were used for synthesis and processing, respectively, whereas thermogravimetry coupled with mass spectrometry was used for phase identification purposes in the coating process. HAp/Ch composite particles exhibited the highest antimicrobial activity against all four microbial strains tested in this work, but after the reconstruction of the bone defect they also caused inflammatory reactions in the newly formed tissue where the defect had lain. Coating HAp with a polymeric blend composed of Ch and PLGA led to a decrease in the reactivity and antimicrobial activity of the composite particles, but also to an increase in the quality of the newly formed bone tissue in the reconstructed defect area.

Indexed as

AnimalsAnti-Infective AgentsBiocompatible MaterialsBone RegenerationCell LineChitosanDurapatiteLactic AcidMicrobial Sensitivity TestsMicroscopy, Electron, ScanningNanoparticlesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymersAnti-Infective AgentsBiocompatible MaterialsChitosanDurapatiteLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymersAntimicrobial activityBone regenerationChitosanHydroxyapatitePLGATGA-on line MS

Identifiers

PMID26706541
PMCPMC4780868
OpenAlexW2178235082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.